While the molecular processes underlying the modulation of β-catenin by TAB182 in ESCC remain to be further elucidated, we discovered that TAB182 physically interacts with β-catenin and prevents it from being phosphorylated by GSK3β and ubiquitination-mediated degradation. This evidence concerns the gene GSK3B and esophageal squamous cell carcinoma.